Combined therapy: What does acamprosate and naltrexone combination tell us?

Alcohol and Alcoholism

Volumn 39, Issue 6, 2004, Pages 542-547

  Kiefer, Falk ^a   Wiedemann, Klaus ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; ALCOHOL; NALTREXONE; NICOTINE; PLACEBO; PSYCHOTROPIC AGENT;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANGER; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEPRESSION; DIARRHEA; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HEADACHE; HUMAN; MONOTHERAPY; NAUSEA; NERVOUSNESS; NONHUMAN; PRIORITY JOURNAL; RELAPSE; SIDE EFFECT; SOMNOLENCE; WITHDRAWAL SYNDROME;

ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; NALTREXONE; TAURINE;

EID: 8844246418     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/agh093     Document Type: Article

References (24)

1. Anton, R. F., Kranzler, H. R. and Meyer, R. E. (1995) Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. Clinical Neuroscience 3, 145-154.
2. Berglund, M., Thealander, S., Salaspuro, Franck, J., Andréasson, S. and Öjehagen, A. (2003) Treatment of Alcohol Abuse: An Evidence-Based Review. Alcoholism: Clinical and Experimental Research 27, 1645-1656.
3. COMBINE Study Group (2003) Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study. Alcoholism: Clinical and Experimental Research 27, 1123-1131.
4. Heinz, A., Lober, S., Georgi, A., Wrase, J., Hermann, D., Rey, E. R., Wellek, S. and Mann, K. (2003) Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alcohol and Alcoholism 38, 35-39.
5. Heyser, C. J., Moc, K. and Koob, G. F. (2003) Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats. Neuropsychopharmacology 28, 1463-1471.
6. Heyser, C. J., Schulteis, G. and Koob, G. F. (1997) Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. Alcoholism: Clinical and Experimental Research 21, 784-791.
7. Johnson, B. A., Roache, J. D., Javors, M. A., DiClemente, C. C., Cloninger, C. R., Priboda, T. J., Bordnick, P. S., Ait-Daoud, N. and Hensler, J. (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. JAMA 284, 963-971.
8. Johnson, B. A., O'Malley, S. S., Ciraulo, D. A., Roache, J. D., Chambers, R. A., Sarid-Segal, O. and Couper, D. (2003) Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects. Journal of Clinical Psychopharmacology 23, 281-293.
9. Kiefer, F., Jahn, H., Tarnaske, T. et al. (2003a) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Archives of General Psychiatry 60, 92-99.
10. Kiefer, F., Jahn, H., Holzbach, R., Briken, P., Stracke, R. and Wiedemann, K. (2003b) Die NALCAM-Studie: Wirksamkeit, Verträglichkeit, Outcome. Sucht 49, 342-351.
11. Kiefer, F., Jahn, H. and Wiedemann, K. (2004) Impact of gender for the pharmacological abstinence maintenance treatment of alcoholism. European Psychiatry 19 (Suppl. 1), 47.
12. Kiefer, F., Helwig, H., Tarnaske, T., Otte, C., Jahn, H. and Wiedemann, K. (2004) Pharmacological relapse prevention of alcoholism: predictors of outcome. European Addiction Research, in press.
13. Kim, S. G., Han, B. D., Park, J. M., Kim, M. J. and Stromberg, M. F. (2004) Effect of the combination of naltrexone and acamprosate on alcohol intake in mice. Psychiatry and Clinical Neuroscience 58, 30-36.
14. Kranzler, H. R. and Van Kirk, J. (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism: Clinical and Experimental Research 25, 1335-1341.
15. Lesch, O. M., Riegler, A., Gutierrez, K., Hertling, I., Ramskogler, K., Semler, B., Zoghlami, A., Benda, N. and Walter, H. (2001) The European acamprosate trials: conclusions for research and therapy. Journal of Biomedical Science 8, 89-95.
16. Mann, K., Lehert, P. and Morgan, M. Y. (2004) The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcoholism: Clinical and Experimental Research 28, 51-63.
17. Mason, B. J. (2001) Treatment of alcohol dependent outpatients with acamprosate: a clinical review. Journal of Clinical Psychiatry 62 (Suppl. 20), 42-48.
18. Mason, B. J., Goodman, A. M., Dixon, R. M., Hameed, M. H., Hulot, T., Wesnes, K., Hunter, J. A. and Boyeson, M. G. ( 2002) A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone. Neuropsychopharmacology 27, 596-606.
19. Spanagel, R. and Holter, S. M. (1999) Long-term alcohol self-administration with repeated alcohol deprivation phases: an animal model of alcoholism? Alcohol and Alcoholism 34, 231-243.
20. Streeton, C. and Whelan, G. (2001) Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol and Alcoholism 36, 544-552.
21. Stromberg, M. F., Mackler, S. A., Volpicelli, J. R. and O'Brien, C. P. (2001) Effect of acamprosate and naltrexone, alone or in combination on ethanol consumption. Alcohol 23, 109-116.
22. Verheul, R., van den Brink, W. and Geerlings, P. (1999) A three-pathway psychobiological model of craving for alcohol. Alcohol and Alcoholism 34, 197-222.
23. Volpicelli, J. R., Clay, K. L., Watson, N. T. and O'Brien, C. R (1995) Naltrexone in the treatment of alcoholism: predicting response to naltrexone. Journal of Clinical Psychiatry 56 (Suppl. 7 , 39-44.
24. Whitworth, A. B., Fischer, F., Lesch, O. M., Nimmerrichter, A., Oberbauer, H., Platz, T., Potgieter, A., Walter, H. and Fleischhacker, W. W. (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347, 1438-1442.